Rafael Lopez-Leon

Cordoba, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

Journal: The Journal of experimental medicine

Published: October 27, 2025

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Journal: Genome medicine

Published: January 06, 2024

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial.

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial.

Journal: Open forum infectious diseases

Published: November 03, 2022

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Journal: medRxiv : the preprint server for health sciences

Published: November 03, 2022

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

Journal: Genome medicine

Published: September 15, 2022

PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States Cohorts.

PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States Cohorts.

Journal: Open forum infectious diseases

Published: January 18, 2022

Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial.

Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial.

Journal: Antimicrobial agents and chemotherapy

Published: December 13, 2021

Risk Factors for Multidrug-Resistant Gram-Negative Bacteria Carriage upon Admission to the Intensive Care Unit.

Risk Factors for Multidrug-Resistant Gram-Negative Bacteria Carriage upon Admission to the Intensive Care Unit.

Journal: International journal of environmental research and public health

Published: December 12, 2021

Recommendations for antibiotic selection for severe nosocomial infections.

Recommendations for antibiotic selection for severe nosocomial infections.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: October 25, 2021

Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial.

Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial.

Journal: BMJ open

Published: November 16, 2020

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Journal: JAMA

Published: September 03, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026